References
- Jarvis WD, Fornari FA Jr., Auer KL, Freemerman AJ, Szabo E, Birrer MJ, Johnson CR, Barbour SE, Dent P, Grant S. Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol Pharmacol 1997; 52:935 - 47; PMID: 9415703
- Niederst MJ, Engelman JA. Bypass mechanisms of resistance to receptor tyrosine kinase inhibition in lung cancer. Sci Signal 2013; 6:re6; http://dx.doi.org/10.1126/scisignal.2004652; PMID: 24065147
- Gentry LR, Martin TD, Der CJ. Mechanisms of targeted therapy resistance take a de-TOR. Cancer Cell 2013; 24:284 - 6; http://dx.doi.org/10.1016/j.ccr.2013.08.021; PMID: 24029226
- Reardon DB, Contessa JN, Mikkelsen RB, Valerie K, Amir C, Dent P, Schmidt-Ullrich RK. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene 1999; 18:4756 - 66; http://dx.doi.org/10.1038/sj.onc.1202849; PMID: 10467423
- Dent P, Reardon DB, Park JS, Bowers G, Logsdon C, Valerie K, Schmidt-Ullrich R. Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death. Mol Biol Cell 1999; 10:2493 - 506; http://dx.doi.org/10.1091/mbc.10.8.2493; PMID: 10436007
- Toulany M, Minjgee M, Saki M, Holler M, Meier F, Eicheler W, Rodemann HP. ERK2-dependent reactivation of Akt mediates the limited response of tumor cells with constitutive K-RAS activity to PI3K inhibition. Cancer Biol Ther 2014; Forthcoming http://dx.doi.org/10.4161/cbt.27311; PMID: 24351425
- Zmajkovicova K, Jesenberger V, Catalanotti F, Baumgartner C, Reyes G, Baccarini M. MEK1 is required for PTEN membrane recruitment, AKT regulation, and the maintenance of peripheral tolerance. Mol Cell 2013; 50:43 - 55; http://dx.doi.org/10.1016/j.molcel.2013.01.037; PMID: 23453810